A Comparison of Topical Nepafenac to Placebo in Corneal Epithelial Healing Times and Postoperative Pain Relief

NCT00330798 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Photorefractive Keratectomy

Interventions

DRUG: nepafenac 0.1%
OTHER: ketorolac 0.4%

Sponsor

Alcon Research

Collaborators

[object Object]